H.R. 1539 · 119th Congress (2025–2027)
Medical Device Electronic Labeling Act
This bill expands the permitted use of electronic labeling of medical devices to allow directions for use and warning labels for all medical devices to be provided electronically, rather than physically (i.e., affixed to or accompanying the device or its container).
(Under current law, direction and warning labels may be provided electronically only for (1) prescription devices intended for use in health care facilities or by health care professionals, and (2) in vitro diagnostic devices intended for use in blood establishments or by health care professionals.)
Under the bill, direction and warning labels may be provided solely electronically for all medical devices so long as (1) the electronic label is readily accessible to the device’s intended users, (2) intended users may request a paper label at no additional cost, and (3) the label affixed to the device or its packaging contains all information required under current laws and regulations.
The Food and Drug Administration may issue regulations establishing additional requirements or exceptions to these provisions.
Show official title
To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 1539’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Jay Obernolte (R-CA-23)
- Cosponsors
7 cosponsors
3 original · 4 later
3 R · 4 D
- Rep. Angie Craig (D-MN-2)· Original · Feb 24, 2025
- Rep. Dan Crenshaw (R-TX-2)· Original · Feb 24, 2025
- Rep. Kevin Mullin (D-CA-15)· Original · Feb 24, 2025
- Rep. Scott H. Peters (D-CA-50)· Later · Apr 8, 2025
- Rep. Mariannette Miller-Meeks (R-IA-1)· Later · Apr 28, 2025
- Rep. Gus M. Bilirakis (R-FL-12)· Later · May 6, 2025
- Rep. Josh Gottheimer (D-NJ-5)· Later · Mar 24, 2026
- Policy area
- Health
- Subjects
- Computers and information technology
- Consumer affairs
- Drug safety, medical device, and laboratory regulation
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Medical Device Electronic Labeling Act
Display title, Short title · Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes.
Official title · Introduced in House